A Scoping Review of 20 Years Breast Cancer Screening Programs in Iran

Pouran Raeissi  Dehkordi; Zeinab  Dolatshahi; Hassan Abolghasem  Gorji; Seyed Massoud  Hashemi; Nahid  Reisi; Toraj Harati  Khalilabad

doi:10.18502/ijph.v54i1.17577

Pouran Raeissi Dehkordi Department of Healthcare Services Management, School of Health Management and Information Sciences, Iran University of Medi-cal Sciences, Tehran, Iran
Zeinab Dolatshahi Department of Healthcare Services Management, School of Health Management and Information Sciences, Iran University of Medi-cal Sciences, Tehran, Iran
Hassan Abolghasem Gorji Department of Healthcare Services Management, School of Health Management and Information Sciences, Iran University of Medi-cal Sciences, Tehran, Iran
Seyed Massoud Hashemi Department of Anesthesiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Nahid Reisi Department of Pediatric Hematology and Oncology, Child Growth and Development Research Centre, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Toraj Harati Khalilabad Department of Healthcare Services Management, School of Health Management and Information Sciences, Iran University of Medi-cal Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/ijph.v54i1.17577

Keywords: Breast cancer; Burden; Epidemiology; Iran

Abstract

Background: Breast cancer (BC) is the leading cancer among women globally. Early detection through screening is vital for reducing mortality, complementing advancements in treatment.

Methods: We aimed to overview BC screening practices in Iran over two-decades to inform policymakers for future research directions and prompt timely diagnoses. A scoping review was conducted on BC studies in Iran from 2000 to 2023, following PRISMA guidelines.

Results: We analyzed 129 articles on BC in Iranian women, and finding six main areas.

Conclusion: Iran's health system lacks an organized BC screening initiative, facing challenges like inadequate infrastructure, sociocultural barriers, unintegrated health insurance packages, and limited research on key indicators.